Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma

Terufumi Kuboa Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, JapanCorrespondence[email protected]

Taro Sugawarab Department of Surgical Pathology, Sapporo Medical University Hospital, Sapporo, Japan

Tomoyo Shinkawaa Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Tomoyo Kurisuc Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Nodoka Kouzenc Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Toshiaki Tanakac Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Fumimasa Fukutac Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Kouji Yamasakic Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Shintaro Sugitab Department of Surgical Pathology, Sapporo Medical University Hospital, Sapporo, Japan

Kazuhiko Matsuod Sapporo Clinical Laboratory Inc., Sapporo, Japan

Rena Moritaa Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Yoshihiko Hirohashia Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Tomohide Tsukaharaa Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Takayuki Kanasekia Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Tadashi Hasegawab Department of Surgical Pathology, Sapporo Medical University Hospital, Sapporo, Japan

Naoya Masumoric Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Toshihiko Torigoea Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan

Your download is now in progress and you may close this window